Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA STRIDES PHARMA SCIENCE DISHMAN PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 30.0 -1,455.3 - View Chart
P/BV x 3.3 3.3 102.1% View Chart
Dividend Yield % 0.7 0.2 346.6%  

Financials

 DISHMAN PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
STRIDES PHARMA SCIENCE
Mar-23
DISHMAN PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs374392 95.5%   
Low Rs129263 48.9%   
Sales per share (Unadj.) Rs197.0408.5 48.2%  
Earnings per share (Unadj.) Rs21.2-25.6 -82.9%  
Cash flow per share (Unadj.) Rs34.71.4 2,536.8%  
Dividends per share (Unadj.) Rs2.001.50 133.3%  
Avg Dividend yield %0.80.5 173.7%  
Book value per share (Unadj.) Rs179.9242.8 74.1%  
Shares outstanding (eoy) m80.7090.30 89.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.8 159.2%   
Avg P/E ratio x11.9-12.8 -92.6%  
P/CF ratio (eoy) x7.3239.6 3.0%  
Price / Book Value ratio x1.41.4 103.6%  
Dividend payout %9.4-5.9 -160.9%   
Avg Mkt Cap Rs m20,30729,603 68.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3557,320 73.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89836,884 43.1%  
Other income Rs m2651,352 19.6%   
Total revenues Rs m16,16338,236 42.3%   
Gross profit Rs m4,103830 494.5%  
Depreciation Rs m1,0912,433 44.8%   
Interest Rs m9442,611 36.2%   
Profit before tax Rs m2,334-2,862 -81.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-553 -112.8%   
Profit after tax Rs m1,710-2,309 -74.1%  
Gross profit margin %25.82.2 1,147.3%  
Effective tax rate %26.719.3 138.3%   
Net profit margin %10.8-6.3 -171.8%  
BALANCE SHEET DATA
Current assets Rs m11,01831,353 35.1%   
Current liabilities Rs m9,51729,902 31.8%   
Net working cap to sales %9.43.9 240.1%  
Current ratio x1.21.0 110.4%  
Inventory Days Days5771 80.1%  
Debtors Days Days3129 2.7%  
Net fixed assets Rs m18,78731,300 60.0%   
Share capital Rs m161903 17.9%   
"Free" reserves Rs m14,35421,025 68.3%   
Net worth Rs m14,51621,928 66.2%   
Long term debt Rs m4,18911,398 36.8%   
Total assets Rs m29,80563,734 46.8%  
Interest coverage x3.5-0.1 -3,617.3%   
Debt to equity ratio x0.30.5 55.5%  
Sales to assets ratio x0.50.6 92.2%   
Return on assets %8.90.5 1,876.8%  
Return on equity %11.8-10.5 -111.9%  
Return on capital %17.5-0.8 -2,330.7%  
Exports to sales %24.946.7 53.3%   
Imports to sales %3.70-   
Exports (fob) Rs m3,95617,213 23.0%   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,95218,113 27.3%   
Fx outflow Rs m697672 103.7%   
Net fx Rs m4,25517,442 24.4%   
CASH FLOW
From Operations Rs m2,786444 627.4%  
From Investments Rs m-1,5293,025 -50.5%  
From Financial Activity Rs m-941-2,139 44.0%  
Net Cashflow Rs m3171,328 23.8%  

Share Holding

Indian Promoters % 61.4 27.4 224.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 38.9 59.1%  
FIIs % 12.0 19.5 61.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 72.6 53.2%  
Shareholders   52,291 91,182 57.3%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs STRIDES PHARMA SCIENCE Share Price Performance

Period Dishman Pharma STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 2.87% 1.16% 1.18%
1-Month -2.45% 0.35% -0.75%
1-Year 96.38% 176.88% 61.82%
3-Year CAGR 89.34% -3.35% 18.16%
5-Year CAGR 38.20% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.